Insiders · NAUT

NAUT insider transactions

Nautilus Biotechnology Inc. (NAUT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NAUT

• 4d
  Large owner Ah Equity Partners Bio Ii, L.L.C. sold $11,750,000 worth of shares (5,000,000 units at $2.35) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  CEO, President, and Secretary Patel Sujal M bought $65,238 worth of shares (25,000 units at $2.61), increasing direct ownership by 0.24% to 10,366,721 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by CFO and Treasurer Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by Chief Scientist Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by CEO, President, and Secretary Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by Chief People Officer Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by Senior VP, Product Development Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by General Counsel Murphy Matthew B.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 96d
  SEC Form 4 filed by Chief Marketing Officer Suzuki Kentaro

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 209d
  Chief Marketing Officer Suzuki Kentaro bought $5,960 worth of shares (4,000 units at $1.49) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 272d
  CEO, President, and Secretary Patel Sujal M bought $135,575 worth of shares (200,000 units at $0.68), increasing direct ownership by 2% to 10,341,721 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 276d
  General Counsel Murphy Matthew B. bought $12,858 worth of shares (20,000 units at $0.64) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 348d
  SEC Form 4 filed by Director Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 348d
  SEC Form 4 filed by Director Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 348d
  SEC Form 4 filed by Director Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 348d
  SEC Form 4 filed by Director Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 348d
  SEC Form 4 filed by Director Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 371d
  CFO and Treasurer Mowry Anna bought $11,488 worth of shares (15,000 units at $0.77), increasing direct ownership by 22% to 83,000 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 392d
  Chief Scientist Mallick Parag bought $9,885 worth of shares (13,500 units at $0.73), increasing direct ownership by 0.07% to 20,493,392 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 444d
  CEO, President, and Secretary Patel Sujal M bought $76,918 worth of shares (77,233 units at $1.00), increasing direct ownership by 0.77% to 10,141,721 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by General Counsel Murphy Matthew B.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by CFO and Treasurer Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by CBO & Senior VP, Bus. Dev. Nelson Nicholas A.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by Chief People Officer Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by Chief Marketing Officer Suzuki Kentaro

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by Chief Scientist Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by CEO, President, and Secretary Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 461d
  SEC Form 4 filed by Senior VP, Product Development Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 621d
  Senior VP, Operations Godwin Mary E. exercised 47,031 shares at a strike of $0.46 and sold $134,744 worth of shares (47,031 units at $2.87) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 628d
  Senior VP, Operations Godwin Mary E. exercised 35,000 shares at a strike of $0.46 and sold $99,869 worth of shares (35,000 units at $2.85) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 629d
  SEC Form 4 filed by Chief Marketing Officer Suzuki Kentaro

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 629d
  SEC Form 3 filed by new insider Suzuki Kentaro

  3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Altman Michael Seth

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Perceptive Advisors Llc

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Pande Vijay Satyanand

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 721d
  SEC Form 4 filed by Director Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 819d
  Patel Sujal M bought $41,478 worth of shares (14,474 units at $2.87), increasing direct ownership by 0.14% to 10,064,488 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 823d
  Patel Sujal M bought $99,054 worth of shares (35,526 units at $2.79), increasing direct ownership by 0.35% to 10,050,014 units (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Nelson Nicholas A.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 825d
  SEC Form 4 filed by Godwin Mary E.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1084d
  SEC Form 4 filed by Perceptive Advisors Llc

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1084d
  SEC Form 4 filed by Altman Michael Seth

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1088d
  SEC Form 4 filed by Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1088d
  SEC Form 4 filed by Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1088d
  SEC Form 4 filed by Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1088d
  SEC Form 4 filed by Pande Vijay Satyanand

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1088d
  SEC Form 4 filed by Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1088d
  SEC Form 4 filed by Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1195d
  SEC Form 4 filed by Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1195d
  SEC Form 4 filed by Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1195d
  SEC Form 4 filed by Murphy Matthew B.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)